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1. Introduction 
Tuberculosis, human immunodeficiency virus/acquired immunodeficiency syndrome and 
malaria are the three most profound cause of death worldwide. In developing country 
tuberculosis is a serious problem. It is estimated that one third of the world’s population is 
infected with M. tuberculosis; however, only a minority (10%) of those infected ever develop 
clinical disease (Corbett et al., 2003). Such clinical diversity suggests that factors other than 
bacterial infection alone determine disease development. Tuberculosis (TB) is a significant 
disease affecting both humans and animals. Susceptibility to Mycobacterium tuberculosis is 
relatively higher in humans than other primates and guinea pigs. Cattle, rabbits and cats are 
susceptible to M. bovis and are quite resistant to M. tuberculosis. 
Each year, 8.8 million patients are newly diagnosed with active TB and 1.6 million patients 
die of TB. The rapid spread of the human immunodeficiency virus has fueled the TB 
epidemic, especially in sub-Saharan Africa, where 28% of TB patients are HIV positive 
(WHO 2007). The current first-line treatment for TB is a multidrug regimen consisting of 
rifampin, isoniazid, pyrazinamide, and ethambutol (RIZE). Several major problems are 
associated with the currently available TB treatment. There is an increasing incidence of 
multidrug-resistant (MDR; resistance to at least rifampin and isoniazid) and extensively 
drug-resistant (XDR; MDR resistance plus resistance to a fluoroquinolone and an 
aminoglycoside) which is creating an alarming situation as far as treatment of the disease is 
concerned. 
1.1 Causes of drug resistance  
The emergence of drug resistance in M. tuberculosis in India has been associated with a 
variety of management, health provider and patient-related factors. These include, deficient 
or deteriorating TB control programs resulting in inadequate administration of effective 
treatment; poor case holding, administration of sub-standard drugs, inadequate or irregular 
drug supply and lack of supervision; ignorance of health care workers in epidemiology, 
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treatment and control; improper prescription of regimens; interruption of chemotherapy 
due to side effects; non-adherence of patients to the prescribed drug therapy; availability of 
anti-TB drugs across the counter, without prescription; massive bacillary load; illiteracy and 
low socio-economic status of the patients; the epidemic of HIV infection; laboratory delays 
in identification and susceptibility testing of M. tuberculosis isolates; use of non-standardized 
laboratory techniques, poor quality drug powders and lack of quality control measures; use 
of anti-TB drugs for indications other than tuberculosis.  
1.2 Initial drug resistance in India 
Indian Council of Medical Research (ICMR) undertook drug resistance studies during 1965-
67 in nine urban areas of the country. However, this exercise was not a surveillance study 
and did not use strict sampling techniques, the centres being selected more for logistic 
considerations than for epidemiological reasons. Sputum specimens collected from all 
patients attending chest clinics were tested for drug susceptibility to streptomycin, 
Isoniazid, para amino salicyctic acid (PAS) and thioacetazone. The first study was on 
patients who had denied any history of previous treatment, while in the second study, 
patients with and without previous chemotherapy was included. The results showed that in 
the first study resistance to Isoniazid ranged from 11-20 per cent, to streptomycin from 8-20 
per cent and to both drugs from 4-11 per cent. The second study showed resistance to 
Isoniazid to range from 15-69 per cent, to streptomycin from 12-63 per cent and to both 
drugs from 5-58 per cent. Further, the level of drug resistance was proportional to the 
duration of previous treatment.  
1.3 Multi drug resistance in other countries 
Resistance towards the responsible pathogens are also seen in developed countries. The 
situation has worsened often due to limited resource available to investigate and provide 
reliable susceptibility data on which rational treatments can be based as well as means to 
optimize the use of antimicrobial agents. The emergence of multi-drug-resistant isolates in 
tuberculosis, acute respiratory infections and diarrhea, often referred to as diseases of 
poverty, has had its greatest toll in developing countries. The epidemic of HIV/AIDS, with 
over 30 million cases in developing countries, has greatly enlarged the population of 
immuno compromised patients. The disease has left these patients at great risk of numerous 
infections and even greater risks of acquiring highly resistant organisms during long 
periods of hospitalization. This article discusses antimicrobial resistance in developing 
countries and the associated risk factors. Magnitude of resistance by regions Africa, 
America, Eastern Mediterranean, European, South East Asian, Western Pacific region has 
shown greater diversity in TB. 
2. Symptoms 
Symptoms of tuberculosis include:  a bad cough that lasts 3 weeks or longer, pain in the 
chest,  coughing up blood or sputum (phlegm from deep inside the lungs). Other symptoms 
of active TB disease are weakness or fatigue, weight loss, no appetite, chills, fever and 
sweating at night. 
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3. Spread  
TB spreads through the air from one person to another. The bacteria are put into the air 
when a person with active TB disease of the lungs or throat coughs or sneezes. People 
nearby may breathe in these bacteria and get infected. When a person breathes in TB 
bacteria, which may settle in the lungs and begin to grow. From there, they can move 
through the blood to other parts of the body, such as the kidney, spine, and brain. TB in the 
lungs or throat can be infectious. This means that the bacteria can spread to other people. TB 
in other parts of the body, such as the kidney or spine, is usually not infectious.People with 
active TB disease are most likely to spread it to people they spend time with every day. This 
includes family members, friends, and coworkers. 
4. Diagnoses 
4.1 Molecular diagnosis of Mycobacterium  
During the past several years, many molecular methods have been developed for direct 
detection, species identification, and drug susceptibility testing of mycobacteria. 
4.1.1 Direct detection of mycobacteria from specimens  
Many mycobacterial species, including M. tuberculosis, grow extremely slowly in the 
laboratory and require 3–8 weeks of incubation on solid medium or at least 2 weeks in a 
radiometric liquid culture system (BACTEC). This slow growth often leads to delay in TB 
diagnosis. Nucleic acid amplification (NAA) methods allow for detection of mycobacterial 
DNA or RNA directly from the specimens before the culture results are available. The Food 
and Drug Administration (FDA) has approved two NAA tests for direct detection of M. 
tuberculosis from clinical specimens. These are the Enhanced Mycobacterium tuberculosis 
Direct Test (E-MTD; Gen-Probe, San Diego, CA) and the Amplicor Mycobacterium 
tuberculosis Test (Amplicor; Roche Diagnostic Systems, Inc., Branchburg, NJ). 
4.1.2 Amplicor test 
Based on PCR assay, Mycobacterium is amplified. After amplification, the amplicons are 
denatured to form single strands and added to a microtiter plate containing a bound, M. 
tuberculosis complex-specific oligonucleotide probe. An avidin-horseradish peroxidase 
conjugate then binds to the bound, biotin-labeled amplicons. The conjugate reacts with 
peroxide and 3, 39, 5, 59-tetramethylbenzidine in dimethylformamide to form a color 
complex. The results are measured with a photometer. 
4.1.3 E-MTD 
The E-MTD test is based on the transcription-mediated amplification system developed by 
Kwoh et al. (1989). In this assay, rRNA is released from the target cells by sonication, and a 
promoter-primer binds to the rRNA target. Reverse transcriptase is then used to copy rRNA 
to a cDNA-RNA hybrid. The initial RNA strand is degraded, and a second primer binds to 
the cDNA and is extended, leading to the formation of double-stranded cDNA, which is 
then transcribed by DNA-directed RNA polymerase to produce more rRNA molecules. The 
new transcripts serve as templates for reverse transcription and further amplification. The 
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RNA amplicons are detected with an acridinium ester-labeled DNA probe in a solution 
hybridization assay. 
4.1.4 DNA probes 
Commercial DNA probes are available for detection of mycobacterium. These are based on 
species-specific DNA probes that hybridize with rRNA released from bacteria. The probes 
are labeled with acridinium ester, and results are measured with a luminometer. 
4.1.5 Line-probe assay 
The Line Probe assay (LiPA; Inno-Genetics N.V., Zwijndrecht, Belgium) has been developed 
for rapid detection of RIF resistance. The test is based on the reverse hybridization method, 
and it consists of PCR amplification of a segment of the rpoB gene and denaturation and 
hybridization of the biotinylated PCR amplicons to capture probes bound to a nitrocellulose 
strip. The bound amplicons are then detected with alkaline phosphatase-conjugated 
streptavidin and BCIP/NBT chromogen, producing a color reaction.  
4.2 TB skin test 
The TB skin test may be used to find out if you have TB infection. You can get a skin test at 
any pathology laboratory. A technician will inject a small amount of testing fluid (called 
tuberculin or PPD) just under the skin on the under side of the forearm. After 48 hours, you 
must return to have your skin test read by the laboratory technician. You may have a 
swelling where the tuberculin was injected. The technician will measure this swelling and 
tell you if your reaction to the test is positive or negative. A positive reaction usually means 
that you have been infected by someone with active TB. 
5. National and international status 
Tuberculosis (TB) is a major, global public health problem, particularly in sub-Saharan 
Africa, where the prevalence of TB is increasing dramatically with the rise of the HIV 
pandemic. One third of the world is infected by Mtb (Mycobacterium tuberculosis). 
(Raviglione et al., 1995). According to the World Health Organization, almost 8 million new 
cases of TB occur annually, with 2 million deaths attributed to the disease each year. There 
were globally an estimated 9.27 million new cases of tuberculosis (TB) and 1.3 million deaths 
in 2007 (WHO, 2009). 
Uganda is one of the world’s 22 highest burden countries with TB, with an estimated annual 
risk of tuberculosis infection of 3% and an annual incidence of new smear positive TB cases 
of 9.2 per 1000 in an urban setting (Guwatudde et al., 2003). Pakistan ranks 7th globally in 
terms of tuberculosis (TB) disease burden (Ansari et al., 2009).  
TB is one of the leading causes of mortality in India  killing more than 300,000 people 
every year. The Human Immunodeficiency Virus (HIV, the virus that causes AIDS) is 
the strongest risk factor for tuberculosis among adults. Tuberculosis is one of the 
earliest opportunistic diseases to develop amongst persons infected with HIV. HIV 
debilitates the immune system increasing the vulnerability to TB and enhancing the risk 
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of progression from TB infection to TB disease. An HIV positive person is six times (50-
60% life time risk) more likely of developing TB disease once infected with TB bacilli, as 
compared to an HIV negative person, who has a 10% life-time risk. Since 1993, the 
Government of India has been implementing the WHO-recommended DOTS strategy 
via the Revised National Tuberculosis Control Programme (RNTCP). The revised 
strategy was pilot-tested in 1993 and launched as a national programme in 1997. By 
March 2006, the programme was implemented nationwide in 633 districts, covering 
1114 million (100%) population. 
India accounts for one fifth of the world's incident TB cases. The reported incidence in 2003 
was 168 per 100,000 and in 2006 is nearly 175 per 100,000. Every year, nearly 2 million 
people die in India, and nearly 1 million cases are smear positive; An estimated 40% of the 
Indian population is latently infected with M. tuberculosis. A number of factors - cultural, 
social, political, economic and technical - have determined the nature of society's response to 
TB. It has been shown that most of the infectious TB cases in a rural community in South 
India. About three-fourths of them are worried about their sickness; and, about half of them 
actively seek treatment for their symptoms at rural medical hospital. The existing facilities 
deal with only a very small fraction of even these patients who are actively seeking 
treatment. The various study report carried out in India has shown increase in TB and MDR-
TB . India is classified along with the sub-Saharan African countries to be among those with 
a high burden of TB.  
5.1 Epidemiology 
The aim of epidemiology is the determination of natural history of disease and 
measurement of its frequency. 
5.1.1 Aims of epidemiology 
 Describe the trends of disease. 
 Evaluation of intervention 
 Define the risk group 
 Frequency, distribution, time, place and person 
6. Available drugs 
6.1 Fluoroquinolone- fluoroquinolone is a promising class of drugs for the treatment of TB 
6.1.1 Moxifloxacin- Moxifloxacin is a broad-spectrum 8-methoxy fluoroquinolone with 
activity against both gram-positive and gram-negative bacteria, including anaerobes. It 
inhibits bacterial DNA gyrase, an enzyme that is essential for the maintenance of DNA 
supercoils. 
6.1.2 Gatifloxacin: Like the other fluoroquinolones, gatifloxacin blocks the bacterial DNA 
gyrase, thereby preventing chromosomal replication. 
6.2 Diarylquinolines. Diarylquinolines have been identified in a process of screening 
various compounds for potential anti-TB activity. 
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Fig. 1. Estimation of annual risk of Tuberculosis in different regions of India 2000-2003 
(From National TB Institute Bangalore). 
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Fig. 2. Annual risk of Tuberculosis infection in South East Asia region. 
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Fig. 3. Model of epidemiology of Tuberculosis. 
6.2.1 TMC207: it inhibits the mycobacterial ATP synthase enzyme 
6.2.2 PA-824. Activated: PA-824 inhibits the synthesis of proteins and cell wall lipids. 
6.3 Nitroimidazopyrans: Nitroimidazopyrans have been derived from the bicyclic 
nitroimidazofurans that were originally developed for cancer chemotherapy but also 
exhibited activity against tuberculosis. 
6.3.1 OPC-67683: OPC-67683 is a mycolic acid biosynthesis inhibitor. 
6.4 Diamines 
6.4.1 SQ109: SQ109 inhibits mycobacterial cell wall synthesis. 
6.5 Pyrroles: In the search for compounds with activity against mycobacteria and fungi, 
several pyrrole derivatives have been developed. 
7. Genetic polymorphisms and tuberculosis 
The genetic contribution of the host plays a significant role in determining susceptibility to 
developing the active form of tuberculosis and severity of infection (Comstock, 1978; Schurr, 
2007). Several genes of host immune response appear to play role in tuberculosis. Genetic 
polymorphisms and tuberculosis have been identified in several genes of host. A number of 
genes have been identified that play important role in tuberculosis (Fernando & Britton, 
2006; Hoal, 2002). Several candidate gene studies and genome-wide linkage association 
studies (Bellamy et al., 2000; Jamieson et al., 2004; Miller et al., 2004; Cooke et al., 2008; 
Berrington & Hawn, 2007) have been performed for investigation of their role in disease 
risk. 
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Infectious disease has profound impact on human evolution. Tuberculosis is a multifactorial 
disorder in which the environment interacts with host-related factors, contributing to the 
overall phenotype. Improved understanding of the individuals balance between degrees of 
exposure and inherited genetic susceptibility to infection, as well as the respective effects of 
environmental and host-related factors will improve the understanding in the development 
of disease. Several host genes have been proven to contribute to active tuberculosis (TB) 
(Pesut, 2009). In human genome different types of variations are reported such as copy 
number variations (CNV), microsatellite repeats (SSR) and single nucleotide polymorphisms 
(SNP). Among these SNPs is the most common type of variations. Presence of 
polymorphisms affects either structure or level of gene products. 
SNP description alone will not be sufficient to describe susceptibility to tuberculosis in a 
broad diverse population, and thus, functional gene studies need to be done. A real 
challenge is to associate candidate genes with a biologically plausible mechanism that 
explains the epidemiological data for tuberculosis in which only 10% of the infected 
individuals will develop tuberculosis. Lienhardt et al., (2002) stated that host-related and 
environmental factors for tuberculosis have usually been investigated separately using 
different study designs. Joint investigation of the genetic, immunologic, and environmental 
factors at play in susceptibility to tuberculosis represents an innovative goal for obtaining a 
better understanding of the pathogenesis of the disease. Host genetic susceptibility has been 
suggested as one of the most important explanations for inter-individual differences in 
tuberculosis (TB) risk. Multi-drug-resistant tuberculosis (MDR TB) is caused by strains of 
the tuberculosis bacteria resistant to the two most effective anti-tuberculosis drugs available-
isoniazid and rifampicin. MDR TB can only be diagnosed in a specialized laboratory. 
8. Genetic polymorphisms in tuberculosis pathogenesis 
8.1 Tumor necrosis factor-alpha (TNF-α) polymorphisms 
The host genetic factor plays a significant role in determining susceptibility to developing 
the active form of tuberculosis (Schurr, 2007). Several host immune response genes appear 
to play role in tuberculosis. Tumor necrosis factor-ǂ (TNF-ǂ) and lymphotoxin-ǂ (LT-ǂ), 
genes located within the MHC III region of chromosome 6, shows close linkage to the HLA 
class I (HLA-B) and class II (HLA-DR) genes (Nedwin et al., 1985) and play role in the 
pathogenesis of tuberculosis due to its role in the formation and maintenance of 
granulomas. It also plays a major role in host defense to M. tuberculosis by its synergistic 
action with interferon-Ǆ (IFN-Ǆ) to activate macrophages and thereby affects disease 
perpetuation (Mohan et al., 2001). Elevated serum TNF-ǂ (sTNF-ǂ) levels have been 
reported in advanced tuberculosis patients compared to those with mild tuberculosis and 
healthy controls. Several promoter polymorphisms region of TNF-ǂ and the intron-1 
polymorphism of LT-ǂ, have been associated with altered levels of TNF-ǂ (Sharma et al., 
2008; 2010). Some of these polymorphisms have also been studied in several ethnic groups. 
Correa Paula et al. (2005) detected TNF-ǂ gene polymorphisms (-308 and -238) in controls 
and patients of several diseases [systemic lupus erythematosus (SLE), rheumatoid arthritis 
(RA), primary Sjogren's syndrome (SS), and tuberculosis (TB)]. TNF -308G was associated 
with TB and -308 GG genotype was protective for autoimmunity. TNF-238A allele was 
protective for autoimmunity but a susceptibility factor for TB. Haplotype -308A-238G have 
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been reported as a protective factor for TB, but susceptibility factor for RA, SLE, and 
primary SS; opposite association of TNF polymorphism with autoimmunity and TB, 
suggested that autoimmune diseases are a consequence of natural selection for enhanced TB 
resistance. Ates et al., (2008), detected TNF-ǂ (-308 G/A, -238 G/A, -376 G/A) and IL10 (-
1,082 G/A, -819 C/T, -592 C/A) polymorphisms in patients with TB and healthy controls. A 
significant association was found between TB and -1,082 G allele. Significant difference was 
observed in IL10 GCC and ACC haplotypes distribution between TB and controls. No 
significant association was found between IL-10 -819 C/T, TNF-ǂ, 308 G/A, -238 G/A, -376 
G/A polymorphisms and Tuberculosis. Sharma et al. 2010, performed a case control study 
including TNF-ǂ gene (-1031, -863, -857, -308,-238) and LT-ǂ gene (+252) polymorphisms in 
North-Indian population. No significant differences of the allele frequencies between the 
tuberculosis patients and controls have been reported. All the polymorphisms included in 
this study did not give a significant association with any of the patient sub-groups but a 
significant difference in the serum TNF-ǂ level in the patients and the controls have been 
reported.  
8.2 ALOX5 polymorphisms  
ALOX5 gene encodes 5-lipoxygenase (5-LO) that play a key role in the biosynthesis of LTs 
and LXs from arachidonic acid. Leukotrienes (LTs) and lipoxins (LXs) are play a role in the 
generation of appropriate responses to inflammatory disease (Parkinson, 2006) and are 
involved in the regulation of immune cells and cytokine release. Phagocytosis of 
microorganisms by alveolar macrophages and polymorphonuclear leukocytes PMN was 
shown to be dependent on LTB4, class of LXs (Bailie, 1996; Mancuso et al., 2001). A T-helper 
cell type 1 immune response is supported by enhanced production of interferon (IFN)- Ǆ and 
interleukin (IL)-12 (Aliberti et al., 2002). The anti-inflammatory properties of LXs antagonize 
those of LTs in innate immunity by inhibiting PMN and NK cell functions, suppressing IL-12 
release and modulating the immune response by stimulation of IL-4 production (Hachicha 
et al., 1999), while blocking IL-5 and IL-13 and inhibiting eosinophil effector functions 
(Bandeira-Melo et al., 2000). A case control study was performed by Herb et al. 2008 
including a variable number of tandem repeats (VNTR) in promoter and an exonic non-
synonymous variant g.760G>A polymorphisms in TB patients and controls from Ghana. 
Carriers of one variant and one wild-type VNTR allele (n = 5) or of the exonic allele g.760A 
had a higher risk of TB. The strongest association with TB was for the ‘non-5/760A’ 
haplotype as compared to the ‘non-5/760G’ haplotype.  
8.3 CD209 polymorphism 
CD209 on chromosome 19p13.3, encodes dendritic Cell-Specific ICAM3-Grabbing Non-
integrin (DC-SIGN), is a C-type lectin, expressed on subsets of dendritic cells (DCs) and 
alveolar macrophages (Soilleux, 2000; Tailleux, 2003). DC-SIGN has ability to bind a variety 
of ligands (Gordon, 2002), endogenous ligands include endothelial cells through ICAM-2, T-
lymphocytes through ICAM-3, neutrophils through MAC-1 and various endogenous 
glycosylated structures (Gordon, 2002; Van Kyook et al., 2003), exogenous ligands such as 
glycosylated moieties on M. leprae, M. tuberculosis,  Bacillus Calmette-Guérin (BCG), H. 
pylori, K. pneumoniae, S. pneumoniae, HIV-1, HIV-2, SIV-1, Dengue virus, Ebola Virus, 
Cytomegalovirus, Hepatitis C virus, S. mansoni, L. pifanoi and C. albicans (Alvarez et al., 2002; 
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Tassaneetrithep et al., 2003). The contribution of CD209 polymorphisms in human 
susceptibility to infectious diseases including M. tuberculosis and M. leprae, HIV-1, and 
Dengue is important (Barreiro et al., 2006). CD209 -336A/G (rs4804803) promoter 
polymorphism have shown an association with infectious disease susceptibility or 
protection in M. leprae case-control study. Martin et al. (2004) demonstrated that the -336G 
allele was associated with susceptibility to parenteral but not mucosal HIV-1 infection, 
although this was not replicated in individuals of recent African descent. Vannberg et al. 
(2008), investigated the role of the CD209 -336A/G polymorphism and susceptibility to 
tuberculosis in sub-Saharan Africans. Significant protection was observed with CD209 -336G 
variant allele in individuals from sub-Saharan Africa and, cases with -336GG were 
significantly less likely to develop tuberculosis-induced lung cavitation. Therefore it has 
been suggested, that decreased levels of the DC-SIGN receptor may be protective against 
both clinical tuberculosis and cavitory tuberculosis disease.  
8.4 SP110 polymorphisms  
Ipr1 gene is attributed to tuberculosis susceptibility gene in mice. Polymorphisms in the 
human homologue, SP110, have been investigated in various populations and only one 
study reports an association with TB susceptibility. Eight SP110 polymorphisms in a South 
African population, including two novel polymorphisms had been investigated. No 
significant association was found with any of the polymorphisms investigated, including 
two polymorphisms that were previously found to be associated with TB susceptibility in 
West African populations (Babb et al., 2007). 
8.5 CARD15 polymorphisms 
Caspase recruitment domain-containing protein 15 genes (CARD15) encodes the nucleotide-
binding oligomerization domain 2 proteins (NOD2) and is considered as a susceptibility 
gene for Crohn's disease (CD). CARD15 gene was investigated as a candidate gene in 
Tuberculosis and its product (NOD2) have been recognized as a non-redundant recognition 
mechanism of M. tuberculosis. Moller et al. 2007, genotyped the R702W, G908R and 1007fs 
variants, in TB cases and controls from the admixed South African Coloured population. No 
statistically significant differences between cases and controls were observed for these 
variants. Previously these polymorphisms have been reported to be associated with CD. The 
CD-associated mutations occur at very low frequencies in this population. The CARD15 is 
not a major susceptibility gene for TB in the South African Coloureds. 
8.6 BTNL2 polymorphisms 
Butyrophilin-like2 gene (BTNL2) gene, a MHC class II gene-linked butyrophilin family 
member, has been recently associated with the inflammatory autoimmune diseases, such as 
tuberculosis, sarcoidosis, and leprosy. BTNL2 was investigated as a candidate gene for 
tuberculosis in the South African Coloured population. Moller et al. (2007) genotyped 18 
SNPs in BTNL2 gene in pulmonary tuberculosis cases and controls. No significant 
association was detected between the truncating rs2076530 SNP, previously associated with 
sarcoidosis, and tuberculosis. No other studied SNPs have shown an association with 
disease and none of the predicted haplotypes showed any association with TB. Comparative 
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analyses of the data from South African, German and American populations revealed that, 
for a segment of BTNL2, the admixed, but not stratified, South African population resembles 
the African-Americans more than white populations. Six SNPs of BTNL2 gene in 
tuberculosis cases and controls in Chinese Han population was investigated by Lian et al. 
2010. No significant association was detected between any of the polymorphisms 
investigated and TB, including rs2076530 SNP that was previously found to be associated 
with sarcoidosis. Genetic study revealed a significant association between the rs3763313, 
rs9268494, rs9268492 SNPs in the BTNL2 gene and tuberculosis. Haplotypes 1–5, and 8 
(C/A/G/T/G/A, C/A/G/T/G/G, C/A/T/G/C/A, C/A/T/G/C/G, and 
C/G/T/G/C/G, T/A/T/G/C/A) presented a significant association with susceptibility to 
tuberculosis.  
8.7 IL1 B, IL4, IL10, IL12B, IL12RB, IL12RB2, IL18, IFN-γ WNT5A, FZD5 gene 
polymorphisms 
Genes involved in the regulation of inflammatory cytokine, interferon gamma, may 
influence tuberculosis susceptibility, as interferon gamma is a major macrophage-activating 
cytokine, during M. tuberculosis infection. Cytokine gene polymorphisms and cytokine levels 
in pulmonary tuberculosis were detected (Selvaraj et al., 2008). Moller et al. (2010), 
investigated fifty-four polymorphisms in eight candidate genes [Interleukin 4 (IL4), 
interleukin 10 (IL10), interleukin 12B (IL12B), interleukin 12 receptor beta 1 (IL12RB1), 
interleukin 12 receptor beta 2 (IL12RB2), interleukin 18 (IL18), wingless-type MMTV 
integration site family, member 5A (WNT5A) and frizzled homolog 5 (FZD5)] in 
tuberculosis cases and healthy controls in South African population. A functional SNP 
(rs2243250, IL-4 -C590T), has been associated with increased promoter strength, stronger 
binding of transcription factors and with different levels of IL-4 activity (Luoni et al., 2001; 
Rosenwasser et al., 1995) but was not associated with TB in study population. The CC 
genotype of this polymorphism was previously associated with protection against 
pulmonary TB in south India and Russia (Naslednikova et al., 2009; Vidyarani et al., 2006) 
but not in Gambia (Bellamy et al., 1998). Two polymorphisms -511 and +3953 in IL1B and 
one in the IL1RN, 86 bp VNTR in smear positive TB patients, and control in Gambian 
individuals (all HIV negative) was investigated. Decreased risk of pulmonary TB was 
associated with both heterozygosity and homozygosity for the IL1B -511-C allele. There was 
no association between the IL1B+3953-T/C polymorphism or the 86 bp IL1RN pentallelic 
repeat and TB in this population. Using an ex-vivo whole blood assay, healthy Gambian 
individuals who are homozygous for the IL1B -511-T allele failed to exhibit a significant 
increase in IL-1ǃ production in response to LPS after IFN-Ǆ priming. 
IFN-Ǆ play a central role in the modulation of Tuberculosis disease severity as it is involved 
in host immune response against M. tuberculosis infection. The 12 CA repeat microsatellite 
allele in the non coding region of the first intron is associated with a high level of in vitro 
cytokine production (Pravica et al., 1999). Recently, it has been reported that, polymorphism 
at position +874 is associated with risk of tuberculosis in different populations (Rossouw et 
al., 2003; Lopez-Maderuelo et al., 2003). Ansari et al. (2009) have reported that the ratio of 
two key cytokines (IFN-Ǆ and IL10) show significant correlation with the severity spectrum 
of tuberculosis in Pakistani population. In this study frequency of cytokine gene 
polymorphisms linked to high and low responder phenotypes (IFNǄ +874 T/A and IL10 -
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1082 G/A) in tuberculosis patients was analyzed. These findings are consistent with the role 
of IL10 in reducing collateral tissue damage and the protective role of IFNǄ in limiting 
disease in the lung.  
A+874T polymorphism on the intron 1 of IFNǄ gene, which is associated with the secretory 
capacity of IFNǄ, was reported to be associated with the development of TB among Sicilians, 
South Africans, Hong Kong Chinese and Spanish, although this association was not found 
in Malawians54 and in other populations from Houston, West Africa, South India and 
China. A recent study of 77 TB patients from Japan revealed that the IFNG + 874 AA 
genotype were strongly and independently predictive of a lower likelihood of sputum 
conversion. Indeed, IL-12, a heterodimeric pro-inflammatory cytokine produced by 
monocytes, macrophages, DCs and B lymphocytes and SNP in the gene responsible in the 
expression of this subunit was first described by Hall et al. (2000). Several polymorphisms in 
promoter, introns and 3′UTR in the IL-12B gene have been reported to be associated with TB 
in various populations, with inconsistent results. Polymorphisms in the coding sequence of 
the IL-12 receptor b1 gene have been reported to be associated with TB in Moroccan and 
Japanese populations, but, again, not in Koreans. Reports indicate that, the IL-12B 
polymorphism is not correlated with susceptibility to tuberculosis in black and white North 
American populations. Four SNPs, 641 A-G, 684 C-T, 1094 T-C, and 1132 G-C causing three 
mis-sense variants (Q214R, M365T and G378R) and one synonymous substitution in the 
extracellular domain of the IL-12R┚1 genes have been detected. Investigators have reported 
that the association of R214-T365-R378 allele (allele 2) is over-expressed in Japanese 
tuberculosis patients with the homozygosis for R214 - T365 - R378 (the 2/2 allele) being 
significantly associated with tuberculosis.  
8.8 IFNγR1 polymorphisms  
Interferon-Ǆ Receptor-1 plays a role in host immune response. Several SNPs in IFNǄR1 have 
been studied in falciparum malaria cases and controls. The frequencies of interferon-Ǆ (IFN-
Ǆ) receptor-1 (IFNǄR1) promoter polymorphisms (G-611A, T-56C) in tuberculosis patients 
and controls were not significantly different. Because of these studied SNP affect 
transcription, the expression of the IFNǄR1 gene does not confer susceptibility to disease in 
patients from Croatia (Bulat-Kardum et al., 2006). A significant association between the 
protective (CA) n polymorphism (22 repeats, 192 FA1), located in intron five of the IFNǄR1 
gene and GT promoter haplotype (-611; -56) that showed the strongest expression capacity 
have been reported. In addition to this cis relationship, the (CA) 22 allele was correlated in 
trans with an IFN-Ǆ SNP (IFNǄ Gþ2109A), which might affect the transcription of the IFNǄ 
gene. These results suggest that a particular combination of IFNǄ and IFNǄR1 SNP (gene-
gene) interaction might provide a better protection against tuberculosis in this population. 
Several families with Mendelian susceptibility to mycobacterial disease that has mutations 
in one of two subunits of the IFN-┛ receptor gene (IFN-┛R1 and IFN-┛R2) (Ottenhoff et al., 
2002) have been discovered. 
8.9 NOS2A polymorphisms  
Nitric oxide (NO) act as is a free radical and second messenger and has been shown to be 
important in the development of several diseases, including tuberculosis. NO, produced by 
NOS2A, plays a major role in the pulmonary host-defense mechanism in response to 
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infections, and is implicated in bacteriostatic as well as bactericidal processes. The cytokines 
like, TNF-ǂ, IL-1ǃ along with IFN-Ǆ produced by T-cells can induce NO via action of 
NOS2A. It has been proposed that NO produced by tuberculosis-infected human 
macrophages and by epithelial cells is anti mycobacterial against M. tuberculosis (Liu et al., 
2006). A report indicates that the alveolar macrophages from the lungs of patients with 
tuberculosis express NOS2A in potentially mycobactericidal amounts and this NOS2A can 
kill mycobacterium in vitro (Qidwai & Jamal, 2010). We have review the role of three SNPs  
(-954G/C, -1173C/T, -1659 A/T), one microsatellite repeat in promoter and one SNP in exon 
16 of gene in several case control studies (Qidwai & Jamal, 2010). The promoter 
polymorphisms (-954G/C, -1173C/T, -1659 A/T) have been shown to increase NO synthesis 
(Hobbs et al., 2002). This region in the human gene is situated from -0.7 to -2.6 kb upstream 
of the transcription start and contains important DNA motifs for binding of NF-κB, activator 
protein 1, signal transducer, and activator of transcription protein 1, and NF-κB repressing 
factor (Coia et al., 2005). The -954G/C variant is believed to have originated as a 
consequence of selective pressure of Plasmodium in endemic area of Africa. The G allele has 
been shown to be absent from Caucasian populations (Kun et al., 1998) as well as from the 
Peruvian population (Martin et al., 1999). In Mexicans, the G allele was not associated with 
tuberculosis (Flores-Villanueva et al., 2005). Two chromosome 17 genes NOS2A and CCL2 
plays a role in susceptibility to tuberculosis in South African population (Moller et al., 2009). 
Haplotype of two functional (rs9282799 and rs8078340) SNPs in the NOS2A promoter have 
been significantly associated with tuberculosis. Presence of T allele decreases the DNA-
protein complex formation and decreases the duration of DNA-protein interaction, which 
leads to decrease NO production. The T allele of SNP rs8078340 is over represented in the 
patients. As NO possess potent antimicrobial effects, having ability to inhibit the growth of 
many infectious organisms in vitro, polymorphism in the promoter alters the level of 
NOS2A, decreasing the level of NO and thereby increases the susceptibility to tuberculosis.  
A case-control association study of TB, patients and controls was performed in African-
Americans and Caucasians by Velez et al. (2009). Thirty-nine SNPs were selected from the 
NOS2A gene, for single SNP, haplotype, and multilocus interaction analyses with other 
typed candidate genes. In African-Americans, ten NOS2A SNPs were associated with TB. 
The strongest associations were observed at rs2274894 and rs7215373. The strongest gene–
gene interactions were observed between NOS2A rs2248814 and IFNGR1 rs1327474 and 
NOS2A rs944722 and IFNGR1 rs1327474. Three other SNPs in NOS2A interacted with TLR4 
rs5030729 and five other NOS2A SNPs interacted with IFNGR1 rs1327474. No significant 
associations were observed in Caucasians. These results suggest that NOS2A variants may 
contribute to TB susceptibility, particularly in individuals of African descent, and may act 
synergistically with SNPs in TLR4 and IFNGR1. 
9. Vitamin D receptor (VDR) polymorphisms 
The investigation of the genetic polymorphisms of vitamin D, VDBP, TLR, NOS2A and IFN-
Ǆ genes and resistance or susceptibility to M. tuberculosis infection was summarized by 
(Preto, 2009). The vitamin D receptor (VDR) gene is one of the most important candidate 
genes that play role in susceptibility to tuberculosis. Polymorphisms that affects the activity 
of the receptor have profound impact. Genetic variants of the natural resistance-associated 
macrophage protein (NRAMP1) and vitamin D receptor (VDR) genes are associated with 
smear-positive pulmonary tuberculosis in Gambian populations (Bellamy et al., 1998a,b; 
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1999). Vitamin D receptor (VDR) genotypes have been shown to be associated with 
differential susceptibility or resistance to tuberculosis. The influence of FokI, BsmI, ApaI and 
TaqI variants of VDR gene on 1, 25(OH)(2) D(3) modulated granzyme A expression of 
cytotoxic lymphocytes induced by culture filtrate antigen (CFA) of Mycobacterium 
tuberculosis (Vidyarani et al., 2009). The ApaI aa genotype and bbaaTT extended genotype 
were associated with a significantly decreased percentage of granzyme A positive cells in 
normal healthy controls. The study suggest that 1, 25(OH)(2) D(3) suppresses granzyme A 
probably by down-regulating Th1 cytokine response.  Gao et al. (2010), has reviewed 
published studies on VDR polymorphisms and TB susceptibility and quantitatively 
summarized associations of the polymorphisms (FokI, TaqI, ApaI and BsmI). Among Asians, 
the FokI ff genotype showed a pronounced positive association, a significant inverse 
association was observed for the BsmI bb genotype, and marginal significant associations 
were found for TaqI and ApaI polymorphisms. None of the studied polymorphisms have 
shown a significant association to TB among Africans or South Americans.  
9.1 Vitamin D-binding protein  
VDBP is a multifunctional, highly expressed, polymorphic serum protein encoded by Gc 
gene and is the major plasma carrier of vitamin D3 and its metabolites and ensures that 
vitamin D is transported to the liver, 25(OH)2D3 to the kidney, and 1, 25(OH)2D3 to target 
cells and organs. A multi gene cluster at chromosome 4q11-q13 includes albumin, ǂ-
fetoprotein and Gc gene. Variations in exon 11 of the Gc gene at codons 416 and 420 give rise 
to electrophoretic variants of VDBP, called Gc1 fast (Gc1F), Gc1 slow (Gc1S) and Gc2 
differing by amino-acid sequence, as well as by attached polysaccharides. Combinations of 
the three VDBP or Gc variants result in six common circulating phenotypes: Gc1F/Gc1F, 
Gc1F/Gc1S, Gc1S/Gc1S, Gc1F/Gc2, Gc1S/Gc2, and Gc2/Gc2 (23). DBP polymorphism (Gc 
phenotype) is related to the VDBP concentration and vitamin D status (Lauridsen et al., 
2005). The authors showed a strong correlation between higher, intermediate and lower 
circulating levels of 25(OH)2D3 and 1,25(OH)2D3 with Gc1-1, Gc1-2 and Gc2-2 phenotypes, 
respectively, in Danish Caucasian postmenopausal women population. Variations in this 
property could affect the functioning of the immune system, as DBP knockout mice 
exhibited an impaired immune response to bacterial infections (White & Cook, 2000). A role 
of DBP polymorphism in autoimmune diabetes mellitus and infectious disease in Polynesia 
and Japan (Hirai et al., 2000) has been suggested. No differences in DBP phenotype were 
seen among patients and the control group. In that study, frequency of Gc2 in tuberculosis 
patients was slightly but not significantly higher than in the control group and this elevation 
was at the expense of both Gc1F and Gc1S alleles. 
9.2 The Toll-like receptors 
The TLRs represent a group of single-pass transmembrane receptors, are expressed on 
innate immune cells and works as sensors for pathogen-derived molecules, and play a role 
in host-pathogen interaction (Aderem et al., 2000). TNF-ǂ and NO is induced mostly by 
macrophages soon after innate recognition of mycobacteria through TLRs (Underhill et al., 
1999). The role of TLR in resistance to M. tuberculosis was suggested initially by the fact that 
MyD88-deficient mice are more susceptible to M. tuberculosis infection and by the 
observation that TRL2/TLR1 reduced the viability of intracellular M. tuberculosis in human 
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monocytes and macrophages, but not in monocyte-derived DCs (Liu et al., 2006). They have 
also reported that TLR induces up-regulation of the VDR, 1ǂ-vitamin D hydroxylase 
(enzyme that converts inactive to active vitamin D), and CYP27B1 gene expression in 
monocytes and macrophages.  
The human TLR2 gene is located on chromosome 4q32 and is composed of 2 non-coding 
exons and 1coding exon (Haehnel et al., 2002). In TLR2 gene, 89 SNPs have been reported, 
(26 in the 5'-untranslated region, 17 in the 3'-untranslated region, 29 located in intronic parts 
of the gene, and 17 modify bases of the third exon of TLR2). Six non-synonymous SNPs of 
the TLR2 gene change amino acids in the cytosolic part of this receptor. Out of which, only 
two have been linked to reducing NF-κB activation and increasing risk of infection. The first 
SNP changes of C to T replacing arginine (Arg; R) with tryptophan (Trp, W) at position 677, 
abolishing the binding with MyD88 with TLR2. This specific polymorphism located within 
the bb loop of TLR2 (Arg677Trp) abolishes activation of NF-κB in response to M. tuberculosis, 
resulting in decreased IL-12 serum level production by 677W carriers. The second TLR2 SNP 
changes G to A, which substitutes an arginine for glutamine at position 753. The TLR2 753Q 
seems to be associated with an increased risk of developing tuberculosis for carriers the AA 
and AG genotypes (Ogus et al., 2004). Thuong et al. (2007) described a strong association of 
SNP T597C TLR2 with susceptibility to military tuberculosis patients from Vietnam. Further 
association was described among Koreans regarding the microsatellite polymorphisms in 
intron II or TLR2 (Yim et al., 2006). In addition, TLR1 polymorphism in a non-synonymous 
region (I602S) could be associated with TLR1/2 heterodimer binding sites to mycobacterial 
lipopeptide, since individuals with 602II genotype produced substantially more IL-6 than 
those with the 602SS variant. Currently, the polymorphism in TLR2 might be an important 
risk factor for disease progression. The G to A (Arg753Gln) polymorphism at position 2258 
in exon 3 and the guanine-thymine (GT) microsatellite repeat polymorphism (100 bp 
upstream of the translational start site) in intron 2, have been associated with susceptibility 
to clinical tuberculosis (TB) disease in Turkish and Korean patients, respectively (Ogus et al., 
2004; Yim et al., 2006). TLR2 promoter region, namely, -16934 A>T and -196 to -174 insertion 
(Ins) >deletion (Del), polymorphisms have been associated with asthma and gastric cancer, 
respectively (Eder et al., 2004; Tahara et al., 2007). 
Patients with pulmonary TB and healthy controls, were examined for TLR2 polymorphisms 
over locus -100 (microsatellite guanine-thymine repeats), -16934 (T>A), -15607 (A>G), -196 to -
174 (insertion>deletion), and 1350 (T>C) (Chen et al., 2010). An association exists between the 
haplotype [A-G-(insertion)-T] and susceptibility to pulmonary tuberculosis. Patients with 
systemic symptoms of tuberculosis had a lower -196 to -174 deletion/deletion genotype 
frequency than those without systemic symptoms. TB patients with the deletion/deletion 
genotype had higher blood NK cell counts than those carrying the insertion allele whereas 
patients with pleuritis had a higher 1350 CC genotype frequency than those without pleuritis. 
Patients of tuberculosis with the 1350 CC genotype had higher blood NK cell counts than those 
carrying the T allele. TB patients carrying homozygous short alleles for GT repeats had higher 
blood NK cell counts than those carrying one or no short allele. Thus, an association between 
the specific TLR2 haplotype and susceptibility to pulmonary TB have been reported. In 
patients with pulmonary TB, both the -196 to -174 Del/ Del and 1350 CC genotypes were 
associated with an increased blood absolute NK cell counts.  
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9.3 TLR4 polymorphism 
Toll-like receptor (TLR) 4 has been described to play a main role in the innate immunity 
against TB. The association between two particular SNPs in human TLR4 (Asp299Gly and 
Thr399Ile) and active TB has been studied in non-HIV Africans with contradictory results. 
However, studies focusing on the effect of these TLR4 SNPs in active TB within a Caucasian 
HIV population are lacking. The association between TLR4 Asp299Gly and Thr399Ile SNPs 
and active TB, in Caucasian Mediterranean HIV-infected individuals were analyzed by 
Ildefonso et al. (2010). Asp299Gly were independently associated with active TB and 
inversely with latent TB prophylaxis. An independent association between TLR4 Asp299Gly 
SNP and active TB in Caucasian Mediterranean HIV-infected patients was detected. 
9.4 Toll-like receptor 8 polymorphisms 
Davila et al. (2008) studied TB association and expression of 18 genes involved in the Toll-
like receptor (TLR) pathways. The polymorphisms in pulmonary TB patients and controls 
from Indonesia was genotyped. The four polymorphisms in the TLR8 gene on chromosome 
X showed evidence of association with TB susceptibility in males, including a non-
synonymous polymorphism rs3764880 (Met1Val).They have also genotyped these four 
TLR8 polymorphisms in an independent collection of pulmonary TB patients and controls 
from Russia and again found evidence of association in males (for rs3764880). A marked 
increase in TLR8 protein expression was also observed directly in differentiated 
macrophages upon infection with M. bovis, bacille Calmette-Gue´rin (BCG). A role for the 
TLR8 gene in susceptibility to pulmonary TB across different populations have been 
reported. Polymorphisms (1805 G/T in TLR1, 2258 A/G in TLR2, -857 C/T and -863 A/C in 
TNF-ǂ and -819 C/T in IL-10) was genotyped in tuberculosis patients and controls by Mai 
Juan et al. 2010. Multivariate logistic regression analysis revealed that the TT genotype of -
857 C/T in TNF-ǂ gene was significantly associated with lower risk of PTB, in comparison 
with other genotypes. The genetic variant of -863 A/C in TNF-ǂ gene was associated with 
susceptibility to PTB and clinical severity of disease. The results of the study suggest that the 
variants in TNF-ǂ gene were associated with susceptibility to PTB and clinical severity of 
disease, while no significant association have been reported for TLRs and IL-10 genes 
polymorphisms and tuberculosis. 
9.5 PTPN22 gene polymorphism 
The PTPN22 gene encodes the lymphoid tyrosine phosphatase that has an important 
regulatory effect on T- and B-cell activation in immune response. Lamsyah et al. (2009) 
reported an association of PTPN22 gene functional variants with development of 
pulmonary tuberculosis in Moroccan population. The two missense polymorphisms of the 
PTPN22 gene (R620W and R263Q) and susceptibility to TB in the Moroccan population was 
investigated. A statistically significant difference exists in  the distribution of the PTPN22 
1885T allele between pulmonary TB patients and healthy controls. In case of PTPN22 R263Q 
(G788A) SNP, there is an increase of 788A allele frequencies in TB patients compared with 
those in healthy individuals. These results suggest that PTPN22 gene variants may affect 
susceptibility to TB in the Moroccan population. 
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9.6 Human V-ATPase polymorphism  
Capparelli et al. (2009) tested for polymorphisms in the intron 15 and the 5′-untranslated 
region of the gene coding for the a3 isoform of the human ATPase gene in pulmonary 
tuberculosis patients and controls. Alleles (two at each site) segregated in the form of four 
haplotype pairs. The double heterozygous patients were protected against tuberculosis and 
the double homozygous patients were susceptible to the disease. 
9.7 MIF, FCGR2A, and FCGR3A gene polymorphisms   
The polymorphisms of macrophage migration inhibitory factor (MIF), Fcg receptors CD16A 
(FCGR3A) and CD32A (FCGR2A) genes and susceptibility to pulmonary tuberculosis (PTB) 
in the Moroccan population, was analyzed (Sadki et al., 2010). The genotyping for MIF-173 
(G/C) (rs755622), FCGR2A-131 H/R (rs1801274), and FCGR3A-158V/F (rs396991) have 
been done. A statistically significant increase of the MIF -173CC homozygote genotype and 
MIF -173*C allele frequencies in PTB patients compared with healthy controls was detected. 
In contrast, no association was observed between FCGR2A-131H/R and FCGR3A-158V/F 
polymorphisms and tuberculosis disease. The finding suggests that MIF -173*C variant may 
play an important role in the development of active tuberculosis. 
9.8 CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms  
Investigation showed that chemokine, chemokine receptor and DC-SIGN gene 
polymorphisms were associated with susceptibility/resistance to HIV and HIV-TB in south 
India (Alagarasu et al., 2009). CCR2 V64I (G/A), monocyte chemoattractant protein-1 (MCP-
1) -2518 A/G, stromal cell derived factor-1alpha; (SDF-1alpha) 3'UTR G/A and DC-SIGN 
gene polymorphisms were studied in HIV-1 infected patients without TB, with pulmonary 
TB (PTB) and extrapulmonary TB, PTB patients without HIV and healthy controls. No 
significant difference was detected in the genotype frequencies of CCR2 V64I, MCP-1 -2518 
and DC-SIGN polymorphisms between the study groups. A significantly increased 
frequency of GG genotype of SDF-1alpha polymorphism was observed among positive for 
HIV and PTB patients compared to healthy controls. The GG genotype of SDF-1alpha 3'UTR 
polymorphism may be associated with susceptibility to PTB in HIV-1 infected patients. 
Raghavan et al. (2009) have detected the HLA-DR2 subtypes and the possible HLA-A/-B/-
DRB1 haplotype combinations that are associated with susceptibility or resistance to HIV 
and HIV with pulmonary tuberculosis (HIV+PTB+). Overrepresentation of HLA-DRB1*1501 
in HIV+PTB- patients and DRB1*1502 in HIV+PTB+ patients as compared to healthy controls 
was detected. An increased frequency of HLA-A2-DRB1*1501 haplotype in HIV+PTB– 
patients and HLA-A2-DRB1*1502 among HIV+PTB+ patients compared to healthy controls 
have been identified. The study suggests that HLA-A2-DRB1*1501 haplotype may be 
associated with HIV infection while HLA-A2-DRB1*1502 haplotype might be associated 
with susceptibility to PTB in HIV patients. HLA-B40-DRB1*1501 and HLA-B40-DRB1*04 
haplotypes may be associated with susceptibility to HIV infection and to PTB in HIV 
patients (Raghvan et al., 2009). 
9.9 TIRAP polymorphisms and susceptibility to childhood TB  
The adaptor protein TIRAP mediates downstream signaling of TLR2 and TLR 4. TIRAP 
gene polymorphisms have been associated with susceptibility and resistance to tuberculosis 
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(TB) in adults in South Africa. Dissanayeke et al. (2009), identified 13 SNPs, and found 
significant differences in frequency of the variants between the two ethnic groups. The 
frequency of individual polymorphisms or combinations did not vary between TB cases and 
controls in either cohort. The 558C→T polymorphism previously associated with TB 
meningitis (TBM) in a Vietnamese population was found to be associated with TBM in the 
mixed ancestry group. The study suggests that, polymorphisms in TIRAP do not appear to 
be involved in childhood TB susceptibility in South Africa. 
10. Mannose-binding lectin (MBL) polymorphisms 
Mannose-binding lectin (MBL) is considered an important component of innate immunity. 
Four functional MBL2 alterations in codons 52, 54, 57 and in the promoter at position c.1-290 
are correlated with significantly lowered MBL serum levels. These variants have been 
associated with susceptibility to a variety of infectious agents as well as with various 
immunologic disorders. The gene encoding MBL is located on chromosome 10 and is 
designated as MBL2. MBL elicits complement activation by binding to mannose- and N-
acetylglucosamine sugar groups on various microorganisms. Variations in the serum MBL 
levels are mainly due to the presence of three common point mutations in exon1 of MBL2 gene 
at the codons 52 (rs5030737), 54 (rs1800451) and 57 (rs1800450). MBL deficiency is an example 
of evolutionary selection, as MBL deficiency reduces the capacity of mycobacteria to invade 
macrophages, thus provide resistance to TB (Garred et al., 1994). Variations at codons 52, 54 
and 57 lead to low or near absent serum MBL. A study from South African suggested that 
hetrozygotes for MBL54 have protection against tuberculosis meningitis (Hoal-Van Helden et 
al., 1999). TB patients as compared to controls have an increased genotype frequencies for 
mutant homozygotes at codons 52, 54 and 57in South Indians but no such association have 
been reported in China, Poland, Turkey, Malawi, Tanzania and Gambia. 
10.1 Complement receptor polymorphisms 
The complement receptor-1(CR1) present on the surface of the macrophages is associated 
with phagocytosis of various microorganisms, including M. tuberculosis. Homozygotes in 
one of five CR1polymorphisms (Q1022H) are associated with increased TB risk in Malawi.  
10.2 Purinergic P2X7 receptor 
Purinergic P2X7 receptors are cationic channels present on the cells in the blood and 
immune systems. A polymorphism with a 1513 A-C (rs3751143) that replaces the glutamic 
acid at residue 496 by alanine, was not associated with pulmonary TB in Gambia (Li et al., 
2002). No link of 1513 SNP with pulmonary TB was found in Southeast Asian refugees from 
Australia but a strong association existed between the C polymorphism and 
extrapulmonary TB (Fernando et al., 2006). 
10.3 Association analysis of susceptibility region on chromosome 5q31 for 
tuberculosis 
In the Asian population the chromosome 5q23.2–31.3 has been identified as a region with 
linkage to tuberculosis (Ridruechai et al., 2010). A putative tuberculosis susceptibility locus 
was investigated, in a family-based association test between the dense SNP markers within 
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chromosome 5q31 and tuberculosis in Thai trio families. Seventy-five SNPs located within 
candidate genes covering SLC22A4, SLC22A5, IRF1, IL5, RAD50, IL13, IL4, KIF3A and 
SEPT8 were genotyped. Association analysis revealed the most significant association with 
tuberculosis in haplotypes comprising SNPs rs274559, rs274554, and rs274553 of SLC22A5 
gene, which remained significant after multiple testing corrections. The two haplotypes 
within the SLC22A4 and KIF3A region were associated with tuberculosis. Haplotypes of 
SLC22A5 were significantly associated with the expression levels of RAD50 and IL13. The 
variants carried by the haplotypes of SLC22A4, SLC22A5, and KIF3A region potentially 
contribute to tuberculosis susceptibility among the Thai population. 
10.4 Genome-wide analysis of genetic susceptibility to tuberculosis  
Bellamy et al. (1998b), performed genome-wide analysis of genetic susceptibility to 
tuberculosis in Africans. A two-stage genome-wide linkage study to search for regions of 
the human genome containing tuberculosis-susceptibility genes was carried out. Sibpair 
families that contain two full siblings, affected by clinical tuberculosis were used. 299 highly 
informative genetic markers, spanning the entire human genome, were typed in 92 sibpairs 
ffrom Gambia and South Africa in the first round. To identify whether any of these regions 
contained a potential tuberculosis-susceptibility gene, 22 markers from these regions were 
genotyped in a second set of 81 sibpairs from the same countries. Markers on chromosomes 
15q and Xq showed suggestive evidence of linkage to tuberculosis. These results indicate 
that genome-wide linkage analysis can contribute to the mapping and identification of 
major genes for multifactorial infectious diseases of humans. Thye et al. (2009) have 
identified a genetic variant, which increases susceptibility to tuberculosis (TB) in African 
populations using genome-wide association (GWA) study. The studies involve analysing 
hundreds of thousands of genetic markers across the human genomes in search of variants 
found in patients but not in healthy controls.  
Control of the TB epidemic requires more than developing new drugs. The diagnostic and 
therapeutic facilities of health care centers in developing countries must be improved, and 
the socioeconomic status and general welfare of patients (including nutritional and HIV 
status) should be addressed to help eradicate TB. The development of tuberculosis or other 
mycobacterial diseases is the result of a complex interaction between the host and pathogen 
influenced by environmental factors. Numerous host genes are likely to be involved in this 
process. A variety of study methods, have contributed to substantial progress in advancing 
our understanding of genetic susceptibility to tuberculosis. 
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